Review

Published on 13 Oct 2022

Tumor-associated macrophages in tumor progression and the role of traditional Chinese medicine in regulating TAMs to enhance antitumor effects

in Cancer Immunity and Immunotherapy

Jiatong Zhang
Jiafeng Gao
Jingwen Cui
Yongqiang Wang
Yipeng Jin
Di Zhang
Degui Lin
Jiahao Lin

Frontiers in Immunology

doi 10.3389/fimmu.2022.1026898

3,372 views
8 citations

Original Research

Published on 12 Oct 2022

Immune-infiltrating signature-based classification reveals CD103+CD39+ T cells associate with colorectal cancer prognosis and response to immunotherapy

in Cancer Immunity and Immunotherapy

Yang Luo
Yunfeng Zong
Hanju Hua
Meiting Gong
Qiao Peng
Chen Li
Dante Neculai
Xun Zeng

Frontiers in Immunology

doi 10.3389/fimmu.2022.1011590

3,244 views
3 citations

Review

Published on 12 Oct 2022

Reshaping the tumor microenvironment: The versatility of immunomodulatory drugs in B-cell neoplasms

in Cancer Immunity and Immunotherapy

Hao Guo
Jingyi Yang
Haoran Wang
Xingchen Liu
Yanyan Liu
Keshu Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2022.1017990

4,210 views
2 citations

Original Research

Published on 12 Oct 2022

Identification of hub genes and their correlation with infiltration of immune cells in MYCN positive neuroblastoma based on WGCNA and LASSO algorithm

in Cancer Immunity and Immunotherapy

Ji Chen
Mengjiao Sun
Chuqin Chen
Bin Jiang
Yongjun Fang

Frontiers in Immunology

doi 10.3389/fimmu.2022.1016683

2,280 views

Original Research

Published on 12 Oct 2022

Significance of macrophage infiltration in the prognosis of lung adenocarcinoma patients evaluated by scRNA and bulkRNA analysis

in Cancer Immunity and Immunotherapy

Huaiyang Zhu
Chunning Zheng
Hongtao Liu
Fanhua Kong
Shuai Kong
Feng Chen
Yuan Tian

Frontiers in Immunology

doi 10.3389/fimmu.2022.1028440

4,786 views
2 citations

Original Research

Published on 11 Oct 2022

Development and validation of four ferroptosis-related gene signatures and their correlations with immune implication in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Ying Zhang
He Ren
Chunting Zhang
Haihua Li
Qingzhi Guo
Haitao Xu
Lina Cui

Frontiers in Immunology

doi 10.3389/fimmu.2022.1028054

5,326 views
8 citations

Review

Published on 11 Oct 2022

The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers

in Cancer Immunity and Immunotherapy

Rong Fan
Nathan De Beule
Anke Maes
Elke De Bruyne
Eline Menu
Karin Vanderkerken
Ken Maes
Karine Breckpot
Kim De Veirman

Frontiers in Immunology

doi 10.3389/fimmu.2022.1016059

3,364 views
5 citations

Original Research

Published on 11 Oct 2022

Characterization of immune features and immunotherapy response in subtypes of hepatocellular carcinoma based on mitophagy

in Cancer Immunity and Immunotherapy

Yanan Wang
Boshizhang Peng
Chun Ning
Shuya He
Huayu Yang
Yilei Mao
Lejia Sun

Frontiers in Immunology

doi 10.3389/fimmu.2022.966167

2,682 views
2 citations

Clinical Trial

Published on 11 Oct 2022

Pembrolizumab in Chinese patients with advanced melanoma: 3-year follow-up of the KEYNOTE-151 study

in Cancer Immunity and Immunotherapy

Lu Si
Xiaoshi Zhang
Yongqian Shu
Hongming Pan
Di Wu
Jiwei Liu
Lili Mao
Xuan Wang
Xizhi Wen
Yanhong Gu

Frontiers in Immunology

doi 10.3389/fimmu.2022.882471

3,186 views
3 citations

Original Research

Published on 11 Oct 2022

Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data

in Cancer Immunity and Immunotherapy

Hongying Zhao
Siwen Zhang
Xiangzhe Yin
Caiyu Zhang
Lixia Wang
Kailai Liu
Haotian Xu
Wangyang Liu
Lin Bo
Shihua Lin

Frontiers in Immunology

doi 10.3389/fimmu.2022.990143

2,625 views
1 citation

Original Research

Published on 11 Oct 2022

Identification and verification of the prognostic value of CUL7 in colon adenocarcinoma

in Cancer Immunity and Immunotherapy

Chengxing Wang
Zhenyu Zhao
Yuhao Zhang
Weijun Liang
Chaorong Zhou
Weixing Lin
Yu He
Meimei Wu
Zijie Meng
Yuehua Liao

Frontiers in Immunology

doi 10.3389/fimmu.2022.1043512

2,979 views

Original Research

Published on 11 Oct 2022

Dynamic analysis of immune status in patients with intracranial germ cell tumor and establishment of an immune risk prognostic model

in Cancer Immunity and Immunotherapy

Hairong Wang
He Huang
Xiaoping Lin
Peidong Chi
Hongyu Chen
Jiangen Chen
Yonggao Mou
Zhongping Chen
Qunying Yang
Chengcheng Guo

Frontiers in Immunology

doi 10.3389/fimmu.2022.1010146

1,588 views

Original Research

Published on 11 Oct 2022

Remodeling the bladder tumor immune microenvironment by mycobacterial species with changes in their cell envelope composition

in Cancer Immunity and Immunotherapy

Jordi Senserrich
Sandra Guallar-Garrido
Elisabet Gomez-Mora
Victor Urrea
Bonaventura Clotet
Esther Julián
Cecilia Cabrera

Frontiers in Immunology

doi 10.3389/fimmu.2022.993401

2,059 views

Review

Published on 11 Oct 2022

Clinical cancer immunotherapy: Current progress and prospects

in Cancer Immunity and Immunotherapy

Chenglong Liu
Mengxuan Yang
Daizhou Zhang
Ming Chen
Di Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2022.961805

16,511 views
22 citations

Original Research

Published on 10 Oct 2022

Identification of N7-methylguanosine related subtypes and construction of prognostic model in gastric cancer

in Cancer Immunity and Immunotherapy

Xiaoxiao Li
Hao Dong
Ling Chen
Yujie Wang
Zhibin Hao
Yingyi Zhang
Yuan Jiao
Zhiyue Zhao
Xiaobo Peng
Xianbao Zhan

Frontiers in Immunology

doi 10.3389/fimmu.2022.984149

3,443 views
2 citations

Original Research

Published on 10 Oct 2022

Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients

in Cancer Immunity and Immunotherapy

Bo Hu
Yan Meng
Chao Qu
Bing-Yan Wang
Dian-Rong Xiu

Frontiers in Immunology

doi 10.3389/fimmu.2022.1018413

4,837 views

Navigation group

Articles

Tumor-associated macrophages in tumor progression and the role of traditional Chinese medicine in regulating TAMs to enhance antitumor effects

Immune-infiltrating signature-based classification reveals CD103+CD39+ T cells associate with colorectal cancer prognosis and response to immunotherapy

Reshaping the tumor microenvironment: The versatility of immunomodulatory drugs in B-cell neoplasms

Identification of hub genes and their correlation with infiltration of immune cells in MYCN positive neuroblastoma based on WGCNA and LASSO algorithm

Significance of macrophage infiltration in the prognosis of lung adenocarcinoma patients evaluated by scRNA and bulkRNA analysis

Development and validation of four ferroptosis-related gene signatures and their correlations with immune implication in hepatocellular carcinoma

The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers

Characterization of immune features and immunotherapy response in subtypes of hepatocellular carcinoma based on mitophagy

Pembrolizumab in Chinese patients with advanced melanoma: 3-year follow-up of the KEYNOTE-151 study

Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data

Identification and verification of the prognostic value of CUL7 in colon adenocarcinoma

Dynamic analysis of immune status in patients with intracranial germ cell tumor and establishment of an immune risk prognostic model

Remodeling the bladder tumor immune microenvironment by mycobacterial species with changes in their cell envelope composition

Clinical cancer immunotherapy: Current progress and prospects

Identification of N7-methylguanosine related subtypes and construction of prognostic model in gastric cancer

Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients